Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with
awareness and attention to comorbidities - ScienceDirect Skip to main contentSkip to article …

There is solid epidemiologic evidence linking psoriasis and psoriatic arthritis (PsA) to
cardiovascular risk factors and an increased risk of developing cardiovascular disease …

Objective To assess the magnitude of risk of cardiovascular and cerebrovascular morbidity
in patients with psoriatic arthritis (PsA) compared with the general population through a …

Objective To assess the incidence and risk factors of cardiovascular events in patients with
psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients …

Psoriatic disease (PsD) is a heterogeneous condition that can affect peripheral and axial
joints (arthritis), entheses, skin (psoriasis) and other structures. Over the past decade …

Imaging techniques such as ultrasonography and MRI have gained ground in the diagnosis
and management of inflammatory arthritis, as these imaging modalities allow a sensitive …

Vascular inflammation is increased in patients with psoriasis. This randomized, double-
blind, multicenter study evaluated the effects of tumor necrosis factor-α antagonist …

Aims Cholesterol efflux capacity (CEC) was recently shown to predict future cardiovascular
(CV) events. Psoriasis both increases CV risk and impairs CEC. However, whether having …

Preclinical and clinical research provide strong evidence that chronic, systemic inflammation
plays a key role in development and progression of atherosclerosis. Indeed, chronic …

Psoriasis, an autoimmune inflammatory disease, with its most common coexisting condition,
psoriatic arthritis, seem to be more than just a local skin or joint disease, as evidence has …